DUBLIN--(BUSINESS WIRE)-- Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per ordinary share. The dividend is payable on February 22, 2011, to shareholders of record on January 31, 2011.
ABOUT COVIDIEN
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2010 revenue of $10.4 billion, Covidien has approximately 42,000 employees worldwide in more than 60 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.
CONTACT:
Covidien plc
Eric Kraus, 508-261-8305
Senior Vice President
Corporate Communications
[email protected]
or
Bruce Farmer, 508-452-4372
Vice President
Public Relations
[email protected]
or
Coleman Lannum, CFA, 508-452-4343
Vice President
Investor Relations
[email protected]
KEYWORDS: Europe Ireland
INDUSTRY KEYWORDS: Health Biotechnology Medical Devices Pharmaceutical Other Health Research Medical Supplies Science
MEDIA:
| Logo |